VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,539,302 | -16.6% | 1,023,384 | -6.7% | 0.04% | -13.3% |
| Q2 2023 | $33,032,197 | -3.2% | 1,097,049 | +4.0% | 0.04% | -8.2% |
| Q1 2023 | $34,114,660 | +22.7% | 1,054,548 | +8.7% | 0.05% | +16.7% |
| Q4 2022 | $27,798,172 | +12.6% | 969,930 | -5.2% | 0.04% | +5.0% |
| Q3 2022 | $24,680,000 | +13.3% | 1,023,212 | +28.6% | 0.04% | +17.6% |
| Q2 2022 | $21,784,000 | -16.3% | 795,619 | +17.3% | 0.03% | -2.9% |
| Q1 2022 | $26,011,000 | +30.9% | 678,244 | +9.3% | 0.04% | +34.6% |
| Q4 2021 | $19,873,000 | +5.4% | 620,429 | -3.1% | 0.03% | -7.1% |
| Q3 2021 | $18,863,000 | -23.0% | 640,064 | -11.3% | 0.03% | -24.3% |
| Q2 2021 | $24,507,000 | +9.7% | 721,211 | +4.9% | 0.04% | 0.0% |
| Q1 2021 | $22,346,000 | -37.1% | 687,519 | -30.3% | 0.04% | -41.3% |
| Q4 2020 | $35,530,000 | -22.2% | 986,388 | -15.4% | 0.06% | -33.0% |
| Q3 2020 | $45,657,000 | +25.0% | 1,165,886 | +17.1% | 0.09% | +11.9% |
| Q2 2020 | $36,522,000 | +75.1% | 995,672 | +10.1% | 0.08% | +44.8% |
| Q1 2020 | $20,862,000 | +38.6% | 904,654 | +76.1% | 0.06% | +87.1% |
| Q4 2019 | $15,052,000 | +20.8% | 513,737 | +10.1% | 0.03% | -3.1% |
| Q3 2019 | $12,458,000 | +50.0% | 466,810 | +44.0% | 0.03% | +52.4% |
| Q2 2019 | $8,308,000 | -10.0% | 324,187 | -21.7% | 0.02% | -19.2% |
| Q1 2019 | $9,232,000 | +35.9% | 413,894 | +28.3% | 0.03% | +18.2% |
| Q4 2018 | $6,794,000 | +14.3% | 322,652 | +0.8% | 0.02% | +29.4% |
| Q3 2018 | $5,946,000 | +17.9% | 320,133 | +40.9% | 0.02% | +13.3% |
| Q2 2018 | $5,044,000 | -17.2% | 227,159 | -18.1% | 0.02% | -21.1% |
| Q1 2018 | $6,092,000 | -46.6% | 277,474 | -43.5% | 0.02% | -47.2% |
| Q4 2017 | $11,409,000 | -24.1% | 491,172 | -25.1% | 0.04% | -30.8% |
| Q3 2017 | $15,039,000 | +7.0% | 655,580 | +2.8% | 0.05% | 0.0% |
| Q2 2017 | $14,059,000 | +12.1% | 637,917 | +16.0% | 0.05% | +6.1% |
| Q1 2017 | $12,538,000 | -3.8% | 549,721 | -12.0% | 0.05% | -10.9% |
| Q4 2016 | $13,034,000 | -28.4% | 624,531 | -9.1% | 0.06% | -32.9% |
| Q3 2016 | $18,204,000 | -8.3% | 687,407 | -4.1% | 0.08% | -10.9% |
| Q2 2016 | $19,862,000 | – | 716,739 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |